Skip to main content
Premium Trial:

Request an Annual Quote

Thermo's Q2 Sales Grow 9 Percent As Profit Tumbles 20 Percent

NEW YORK (GenomeWeb News) — Thermo Electron today reported that total second-quarter revenue increased 9 percent though profits tumbled 20 percent.
 
Total receipts for the three months ended July 1 increased to $713 million from $654 million during the same period one year ago.
 
Its Life and Laboratory Sciences segment led the drive with an 11 percent increase to $539 million from $487 million in the year-ago period. Revenues from the firm’s Measurement and Control segment rose 5 percent to $174 million from $166 million in Q2 2005.
 
Net income for the quarter sank 20 percent to $47.9 million from $60.2 million in the year-ago quarter.
 
Research and development costs for the quarter dipped 3 percent to $40.6 million from $39.4 million year over year.
 
As of July 1, Thermo Electron had $189.7 million in cash and cash equivalents.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.